PathoNostics B.V.

PathoNostics B.V. specializes in multiplex real-time PCR diagnostic kits. These kits are designed to detect and differentiate fungal pathogens, such as *Pneumocystis*, *Mucor*, *Aspergillus*, and skin-associated fungal species. The company’s product line includes standalone multiplex assays, resistance-tested multiplex kits, as well as calibration and extraction reagents. These tools are intended for use in clinical microbiology laboratories to support accurate fungal infection diagnosis.

PathoNostics B.V. is based in the Netherlands, an EU member state. This location allows its devices to be registered and listed in the EU’s central database, eudamed, which tracks In Vitro Diagnostic (IVD) devices authorized under EU regulations. The company’s devices must comply with EU IVD Directive or IVDR requirements, ensuring they meet safety, performance, and regulatory standards before being placed on the market.

PathoNostics B.V.’s devices fall under EU In Vitro Diagnostic Device (IVD) classifications, specifically Class A and Class B, with some listed under the broader IVD General category. Classification depends on factors like the intended use, risk level, and potential health impact of the device. For example, kits designed for detecting fungal pathogens may be classified as Class B due to their role in diagnosing serious infections, requiring higher scrutiny to ensure accuracy and safety.

PathoNostics B.V.’s devices are registered in the eudamed database, which is the official EU registry for In Vitro Diagnostic (IVD) devices authorized under EU regulations. Listing in eudamed confirms compliance with EU IVD requirements, including manufacturing standards, performance validation, and post-market surveillance. This registry is publicly accessible and ensures transparency for healthcare professionals and regulatory authorities.

The primary purpose of PathoNostics B.V.’s multiplex real-time PCR kits is to aid in the accurate diagnosis of fungal infections by detecting and differentiating specific fungal pathogens. These kits are designed for clinical microbiology laboratories, where rapid and precise identification of infections—such as those caused by *Aspergillus*, *Mucor*, or *Pneumocystis*—can significantly influence patient treatment decisions. The multiplex format allows simultaneous testing of multiple targets, improving efficiency and reducing turnaround time.